The current valuation score of VolitionRX Ltd is 9.31, ranking 40 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.21, which is 0.00% below the recent high of -0.21 and -5992.72% above the recent low of -12.72.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.